Home

CorFlow Therapeutics has announced that the company has been granted Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Controlled Flow Infusion (CoFI) System. It is indicated for the diagnostic assessment of the coronary microcirculation immediately after percutaneous coronary interventions (PCI) and as a platform for controlled infusion of therapeutic agents into the microcirculation, with or without vessel occlusion.

Commenting in a press release from the company, CEO and co-founder Jon H Hoem says: “The FDA Breakthrough Designation approval is an important validation of the vision the CorFlow founders had when founding the company in June 2016: to develop a technology which fits the workflow for acute heart attack patients and which provides a diagnostic tool as well as a therapeutic platform for the coronary microcirculation. It also reflects the true spirit of the CorFlow team and how the team achieves demanding milestones which will bring the CorFlow technology to patients in need of improved coronary microcirculation.”

CorFlow says it is pleased to be on an accelerated track to bring the CoFI System to the US market and looks forward to continuing the cooperation with the FDA to ensure that this critical technology is available to the patients in need. The statement says that the company continues to enrol patients into the ongoing European First-in-Man MOCA I clinical trial and will expedite the US submissions for clinical trials in light of the Breakthrough Designation. The MOCA I trial is a safety and feasibility trial in 40 acute heart attack patients.

The FDA Breakthrough Designation Program was launched in December 2018 and is granted to medical devices that have the potential to provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The objective of the programme is to provide patients and healthcare providers timely access to novel medical devices by speeding their development, assessment and review, while preserving the standards for medical device approvals. The Centers for Medicare & Medicaid Services (CMS) has also instituted a new rule that will increase payments for medical devices designated by the FDA as breakthrough devices.

Source CardiovascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua google bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua twitter bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua MySpace bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua LinkedIn bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua stumbleupon bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua icio bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua digg bài: US FDA grants Breakthrough Device designation to CorFlow

Chia sẽ qua yahoo bài: US FDA grants Breakthrough Device designation to CorFlow

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.